Literature DB >> 8497053

Dissociation of progeny vaccinia virus from the cell membrane is regulated by a viral envelope glycoprotein: effect of a point mutation in the lectin homology domain of the A34R gene.

R Blasco1, J R Sisler, B Moss.   

Abstract

Vaccinia virus strains vary considerably in the amounts of extracellular enveloped virus (EEV) that they release from infected cells. The IHD-J strain produces up to 40 times more EEV than does the related WR strain and consequently generates elongated comet-shaped virus plaques instead of sharply defined round ones in susceptible monolayer cells under liquid medium. The difference in EEV formation is due to the retention of enveloped WR virions on the cell surface (R. Blasco and B. Moss, J. Virol. 66:4170-4179, 1992). By using WR and IHD-J DNA fragments for marker transfer and analyzing the progeny virus by the comet formation assay, we determined that gene A34R and at least one other gene regulate the release of cell-associated virions. Replacement of the A34R gene of WR with the corresponding gene from IHD-J increased the amount of EEV produced by 10-fold and conferred the ability to form distinctive comet-shaped plaques. Gene A34R encodes an EEV-specific glycoprotein with homology to C-type animal lectins (S.A. Duncan and G.L. Smith, J. Virol. 66:1610-1621, 1992). The nucleotide sequences of the A34R genes of WR and IHD-J strains differed in six positions, of which four were silent. One of the codon mutations (Lys-151-->Glu), which is located in the putative carbohydrate recognition domain, was sufficient to transfer a comet-forming phenotype to WR virus. These data indicate that the A34R-encoded glycoprotein is involved, through its lectin homology domain, in the retention of progeny virus on the surface of parental cells and raise the possibility that the protein also has a role in virus attachment to uninfected cells.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8497053      PMCID: PMC237674          DOI: 10.1128/JVI.67.6.3319-3325.1993

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  27 in total

1.  Nucleotide sequence of 42 kbp of vaccinia virus strain WR from near the right inverted terminal repeat.

Authors:  G L Smith; Y S Chan; S T Howard
Journal:  J Gen Virol       Date:  1991-06       Impact factor: 3.891

2.  Role of cell-associated enveloped vaccinia virus in cell-to-cell spread.

Authors:  R Blasco; B Moss
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

3.  Extracellular vaccinia virus formation and cell-to-cell virus transmission are prevented by deletion of the gene encoding the 37,000-Dalton outer envelope protein.

Authors:  R Blasco; B Moss
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

4.  Vaccinia virus reexamined: development and release.

Authors:  C Morgan
Journal:  Virology       Date:  1976-08       Impact factor: 3.616

5.  A constitutively expressed vaccinia gene encodes a 42-kDa glycoprotein related to complement control factors that forms part of the extracellular virus envelope.

Authors:  M Engelstad; S T Howard; G L Smith
Journal:  Virology       Date:  1992-06       Impact factor: 3.616

6.  Biogenesis of poxviruses: role of A-type inclusions and host cell membranes in virus dissemination.

Authors:  Y Ichihashi; S Matsumoto; S Dales
Journal:  Virology       Date:  1971-12       Impact factor: 3.616

7.  Nucleotide sequence of 21.8 kbp of variola major virus strain Harvey and comparison with vaccinia virus.

Authors:  B Aguado; I P Selmes; G L Smith
Journal:  J Gen Virol       Date:  1992-11       Impact factor: 3.891

8.  Polypeptide composition of extracellular enveloped vaccinia virus.

Authors:  L Payne
Journal:  J Virol       Date:  1978-07       Impact factor: 5.103

9.  Characterization of vaccinia virus glycoproteins by monoclonal antibody precipitation.

Authors:  L G Payne
Journal:  Virology       Date:  1992-03       Impact factor: 3.616

10.  Identification and characterization of an extracellular envelope glycoprotein affecting vaccinia virus egress.

Authors:  S A Duncan; G L Smith
Journal:  J Virol       Date:  1992-03       Impact factor: 5.103

View more
  80 in total

Review 1.  Directed egress of animal viruses promotes cell-to-cell spread.

Authors:  David C Johnson; Mary T Huber
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

2.  Identification of second-site mutations that enhance release and spread of vaccinia virus.

Authors:  Ehud Katz; Elizabeth Wolffe; Bernard Moss
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

3.  Mutations in the vaccinia virus A33R and B5R envelope proteins that enhance release of extracellular virions and eliminate formation of actin-containing microvilli without preventing tyrosine phosphorylation of the A36R protein.

Authors:  Ehud Katz; Brian M Ward; Andrea S Weisberg; Bernard Moss
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

4.  There is an A33-dependent mechanism for the incorporation of B5-GFP into vaccinia virus extracellular enveloped virions.

Authors:  Winnie M Chan; Brian M Ward
Journal:  Virology       Date:  2010-04-07       Impact factor: 3.616

5.  Vaccinia virus entry into cells via a low-pH-dependent endosomal pathway.

Authors:  Alan C Townsley; Andrea S Weisberg; Timothy R Wagenaar; Bernard Moss
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

6.  Chimpanzee/human mAbs to vaccinia virus B5 protein neutralize vaccinia and smallpox viruses and protect mice against vaccinia virus.

Authors:  Zhaochun Chen; Patricia Earl; Jeffrey Americo; Inger Damon; Scott K Smith; Yi-Hua Zhou; Fujuan Yu; Andrew Sebrell; Suzanne Emerson; Gary Cohen; Roselyn J Eisenberg; Juraj Svitel; Peter Schuck; William Satterfield; Bernard Moss; Robert Purcell
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-25       Impact factor: 11.205

7.  The vaccinia virus B5 protein requires A34 for efficient intracellular trafficking from the endoplasmic reticulum to the site of wrapping and incorporation into progeny virions.

Authors:  Amalia K Earley; Winnie M Chan; Brian M Ward
Journal:  J Virol       Date:  2007-12-19       Impact factor: 5.103

8.  The vaccinia virus F13L YPPL motif is required for efficient release of extracellular enveloped virus.

Authors:  Kady M Honeychurch; Guang Yang; Robert Jordan; Dennis E Hruby
Journal:  J Virol       Date:  2007-05-02       Impact factor: 5.103

9.  Vaccinia virus A43R gene encodes an orthopoxvirus-specific late non-virion type-1 membrane protein that is dispensable for replication but enhances intradermal lesion formation.

Authors:  Cindy L Sood; Bernard Moss
Journal:  Virology       Date:  2009-11-08       Impact factor: 3.616

10.  Crosstalk between immune cell and oncolytic vaccinia therapy enhances tumor trafficking and antitumor effects.

Authors:  Padma Sampath; Jun Li; Weizhou Hou; Hannah Chen; David L Bartlett; Steve H Thorne
Journal:  Mol Ther       Date:  2012-12-11       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.